Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/46339
Title: Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment
Authors: Elagin, V. V.
Bratchikov, O. I.
Zatolokina, M. A.
Keywords: medicine
pharmacology
acute kidney injury
ischemic-reperfusion kidney
endothelial dysfunction
pharmacological preconditioning
asialoerythropoietin
selective inhibitor of arginase
Issue Date: 2018
Citation: Elagin, V.V. Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment / V.V. Elagin, O.I. Bratchikov, M.A. Zatolokina // Research Results in Pharmacology. - 2018. - Vol. 4, № 4.- P. 29-40. - Doi: 10.3897/rrpharmacology.4.31846. - Refer.: p. 39-40.
Abstract: Acute kidney injury (AKI), which is based on ischemic-reperfusion damage, is a widespread life-threatening condition and remains a serious public health problem with a high mortality rate among patients. Pharmacological preconditioning and the use of endothelioprotectors are promising areas in this field, therefore the purpose of this study was to analyze the nephroprotective properties of asialoerythropoietin and selective inhibitor of arginase II KUD975 in ischemic kidney damage in the experiment
URI: http://dspace.bsu.edu.ru/handle/123456789/46339
Appears in Collections:Vol. 4, № 4

Files in This Item:
File Description SizeFormat 
Elagin_Correction.pdf1.99 MBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.